<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Latest News</title>
    <description>Latest news from the Irish Pharmaceutical Healthcare Association and the international research-based pharmaceutical industry in Ireland and globally.</description>
    <generator>Arekibo IMS - http://www.arekibo.com</generator>
    <language>en</language>
    <link>http://www.ipha.ie/news/latest-news.aspx
	</link>
    <item>
      <title>The Stability Treaty will protect Ireland’s industrial sector – IPHA</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=600582a9-2245-43c0-bed9-a69326e40b60</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=600582a9-2245-43c0-bed9-a69326e40b60</guid>
      <description>It is very much in Ireland’s interests to ensure that the Stability Treaty is ratified in the forthcoming referendum if we want to see the tentative economic recovery maintained and our industrial sector protected, according to David Gallagher, Irish Pharmaceutical Healthcare Association (IPHA) President. </description>
    </item>
    <item>
      <title>IPHA welcomes IMO stance on access to new medicines</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=40699a6f-40b7-4a88-a17e-1f9ebff88aa7</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=40699a6f-40b7-4a88-a17e-1f9ebff88aa7</guid>
      <description>The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed the tabling of a motion at the Annual Conference of the Irish Medical Organisation (IMO) regarding patient access to new medicines.</description>
    </item>
    <item>
      <title>Latest Edition of Facts and Figures 2012 now available</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=90471bc5-9ebe-4f46-a42a-da2a30cf9e9d</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=90471bc5-9ebe-4f46-a42a-da2a30cf9e9d</guid>
      <description>Healthcare Facts and Figures 2012 provides detailed facts and figures about healthcare in Ireland and the pharmaceutical and healthcare industry both nationally and globally.</description>
    </item>
    <item>
      <title>Support of biopharmaceutical sector in new jobs plan a welcome recognition, but unprecedented challenges must be addressed</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=4fb41c0d-1db1-477d-966e-4e73dc73b22f</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=4fb41c0d-1db1-477d-966e-4e73dc73b22f</guid>
      <description>Expert forum calls for Government to support innovation to protect one of Ireland’s greatest economic success stories</description>
    </item>
    <item>
      <title>Latest Issue of Medicines Matter February 2012 now available </title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=5480f72d-5787-4286-9d39-492185974f98</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=5480f72d-5787-4286-9d39-492185974f98</guid>
      <description>In this issue: IPHA Annual Meeting and Dinner 2011; IPHA view on reference pricing; revised Marketing Code; new appointments; company news; medicines.ie goes from strength to strength; the pharmaceutical industry and innovation and more.</description>
    </item>
    <item>
      <title>IPHA responds to ESRI report on use of pharmaceuticals</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=5c30bf6e-386b-4056-9c61-6385a7c5a82e</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=5c30bf6e-386b-4056-9c61-6385a7c5a82e</guid>
      <description>The Irish Pharmaceutical Healthcare Association (IPHA) has responded to the HSE commissioned report by the ESRI, Delivery of Pharmaceuticals in Ireland – Getting a Bigger Bang for the Buck.</description>
    </item>
    <item>
      <title>Revised Code of Marketing Practice for the Pharmaceutical Industry (Edition 7.5)</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=d0bf2c14-7837-476f-b611-2bcab0d39fda</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=d0bf2c14-7837-476f-b611-2bcab0d39fda</guid>
      <description>
      </description>
    </item>
    <item>
      <title>Benefits of pharmaceutical innovation far exceed health costs</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=afdd2753-b532-48f6-b9a9-372584b63347</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=afdd2753-b532-48f6-b9a9-372584b63347</guid>
      <description>Benefits of pharmaceutical innovation far exceed health costs

Longevity and economic growth go hand in hand with innovation in the research-based pharmaceutical industry, according to Professor Frank Lichtenberg, of the Columbia Graduate School of Business, Columbia University, New York.
</description>
    </item>
    <item>
      <title>IPHA response to ESRI Budget Perspectives (2012)</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=c48591f6-0eba-488c-8789-94e72564d267</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=c48591f6-0eba-488c-8789-94e72564d267</guid>
      <description>The supply of medicines to the health services by pharmaceutical companies has been governed by a series of agreements between the State and the Irish Pharmaceutical Healthcare Association (IPHA), on behalf of the international research-based pharmaceutical industry. The current agreement was implemented in September 2006 and will run until March 2012. During its time, it is estimated that it will have delivered savings to the State of over €300 million.</description>
    </item>
    <item>
      <title>New Member Elected to the Board of the Irish Pharmaceutical Healthcare Association</title>
      <link>http://www.ipha.ie/news/latest-news.aspx?article=fcfaf085-671d-494e-9315-039e84ab90d7</link>
      <guid>http://www.ipha.ie/news/latest-news.aspx?article=fcfaf085-671d-494e-9315-039e84ab90d7</guid>
      <description>The Irish Pharmaceutical Healthcare Association (IPHA) is pleased to announce the election of Dr. David Hall PhD MEng MBA to the Board of Directors of the Association.</description>
    </item>
  </channel>
</rss>
